NFKB1 and adult T-cell leukemia/lymphoma: This study identified NIK, a positive regulator of the non-canonical NF-κB pathway, as an important target of miR-31; Polycomb-mediated epigenetic silencing of miR-31 causes aberrant overexpression of NIK in ATLL cells, thus contributing to NF-κB activation [135].